Omrix Biopharmaceuticals

About:

Omrix Biopharmaceuticals develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Website: http://www.omrix.com

Top Investors: Hercules Capital, MPM Capital, Thuja Capital, Catalyst Fund LP

Description:

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Total Funding Amount:

$26.5M

Headquarters Location:

Qiryat Ono, Tel Aviv, Israel

Founded Date:

1995-01-01

Contact Email:

webmaster(AT)ethus.jnj.com

Founders:

Robert Taub

Number of Employees:

501-1000

Last Funding Date:

2007-02-15

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai